Redox metabolism modulation as a mechanism in SSRI toxicity and pharmacological effects
- 4 April 2020
- journal article
- review article
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (5) , 1417-1441
Abstract
Depressive disorders are amongst the greatest mental health challenges, with an increasing number of patients being diagnosed each year. Though it has not yet been fully elucidated, redox metabolism imbalances and oxidative stress seem to play a major role in the pathogenesis of depressive disorders. Selective serotonin reuptake inhibitors (SSRIs) are the most prescribed antidepressants, considered to have a better tolerability. However, several adverse effects have been reported and the mechanisms involved in their pharmacological activity are not entirely understood. SSRIs have been shown to influence the redox metabolism, which could be involved in their toxicity and pharmacological effects. A comparative analysis of published in vivo and in vitro data regarding the activity of SSRIs on the redox metabolism pathways has been performed in this paper, with an emphasis on mechanistical aspects. Furthermore, a comparison between oxidative stress biomarker levels reported by different studies was attempted. The reviewed data point towards both pro- and antioxidant effects of SSRIs, dependent on tissue/cell type and dose/concentration, suggest a redox modulating potential of these compounds. In hepatic and testicular tissue, the majority of reviewed studies reported pro-oxidant effects, with possible implications towards the hepatotoxicity and sexual dysfunction that were reported following SSRI treatment; while in brain, the most common findings were antioxidant effects that could partially explain their antidepressant activity. However, given the heterogeneity of the reviewed data, further research is needed to fully understand the impact of SSRIs on redox metabolism and its implications.Keywords
This publication has 105 references indexed in Scilit:
- Biological markers of oxidative stress: Applications to cardiovascular research and practiceRedox Biology, 2013
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signalingCellular Signalling, 2012
- Etiology of Depression: Genetic and Environmental FactorsPsychiatric Clinics of North America, 2012
- Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stressJournal of Psychiatric Research, 2012
- Cytochrome P450 enzymes in the brain: emerging evidence of biological significanceTrends in Pharmacological Sciences, 2011
- Nitric oxide modulation in protective role of antidepressants against chronic fatigue syndrome in miceIndian Journal of Pharmacology, 2011
- Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissueBMC Gastroenterology, 2009
- The molecular neurobiology of depressionNature, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?British Journal of Pharmacology, 2004